Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Prescription Dermatological Drugs: Worldwide Market, 6th Edition

Prescription Dermatological Drugs: Worldwide Market, 6th Edition

One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.

Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.

In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.

Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:

Acne and Rosacea

Antiaging and Photodamage

Dermatitis and Seborrhea

Fungal Infections

Hair Loss and Hair Removal

Hyperpigmentation/Melasma

Psoriasis

Skin Cancer, and

Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:

United States

Europe

Japan

Rest of world

The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:

Allergan Inc.

Allergan Inamed Corporation

Barrier Therapeutics, Inc

Bayer AG

Bradley Pharmaceuticals, Inc

Bristol-Myers Squibb

CollaGenex Pharmaceuticals

Galderma S.A.

Genentech, Inc.

GlaxoSmithKline Plc

Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)

Medicis Pharmaceutical Corporation

Merck & Company, Inc.

Mylan Pharmaceuticals, Inc,

Novartis Pharmaceuticals Corporation

Nycomed Inc.

Pfizer, Inc.

Q-Med AB

Roche Group (F. Hoffmann-La Roche Ltd.)

Schering-Plough Corporation

Sinclair Pharma Plc.

SkinMedica

Stiefel Laboratories, Inc.

Valeant Pharmaceuticals, Inc.

Jan 1, 2008

330 Pages - Pub ID: KLI1399532
Table of Contents
Sample Pages (PDF)

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions